Esperion Therapeutics
ESPR
#6721
Rank
S$0.66 B
Marketcap
$3.39
Share price
2.02%
Change (1 day)
102.36%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -S$54.54 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.27 Billion. In 2023 the company made an earning of -S$0.21 Billion, an increase over its 2022 earnings that were of -S$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$54.54 Million-73.03%
2023 -S$0.21 Billion-15.03%
2022 -S$0.24 Billion-20.61%
2021 -S$0.3 Billion84.28%
2020 -S$0.17 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.28 Billion19.57%
2017 -S$0.23 Billion125.39%
2016 -S$0.11 Billion51.43%
2015 -S$66.29 Million36.45%
2014 -S$48.58 Million43.55%
2013 -S$33.85 Million145.26%
2012 -S$13.8 Million
2002 -S$39.34 Million-7.81%
2001 -S$42.67 Million15.03%
2000 -S$37.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.52 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.64 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.68 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.28 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA